Gathering more than 300 industry pioneers, Cell & Gene Therapy World Asia has been a premier event since 2017. The goal of the conference is to promote research, development, and production of high-quality regenerative medicines and cell and gene treatments across Asia.

This year’s event will address the following topics: next-generation CAR-T medicines, advancements in CAR-T manufacturing, best practices in the region, scale-out strategies, cost optimization, commercialization readiness, and regulatory case studies. Come network with influential people and up-and-coming businesses including Fosun Kite Biotechnology, Gracell Biotechnologies, BeiGene, and more. All under one roof, learn about the most recent advancements in R&D and commercialization, as well as industry demands and special case studies.